Today in FirstWord: Boehringer Ingelheim, Eli Lilly, empagliflozin, Celgene, Novartis, Gilead Sciences

FirstWord Pharmaceutical News for Monday, March 24, 2014

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Monday, March 24, 2014

Sign up to save your podcasts

FirstWord Pharmaceutical News for Monday, March 24, 2014

FirstWord Pharmaceutical News for Monday, March 24, 2014